Fujian Shengdi Pharmaceutical Co., Ltd.

This study tested a new tablet called HRS9531 in 166 adults with obesity (BMI 28-40). Participants took the tablet or a placebo for 26 weeks to see how much weight they lost. The goal was to find a safe and effective way to help manage body weight over time.

This early-stage study tested a single injection of HRS-7249 in 32 to 48 healthy adults with mildly to moderately high cholesterol. The main goal was to check safety and how the drug moves through the body. Participants received either the drug or a placebo, and researchers monit…

This early-stage study tested a new medicine called HRS-4729 in 102 healthy adults who were overweight or had obesity. The main goal was to check if the drug is safe and how the body processes it. Participants received either the drug or a placebo as a shot under the skin, and re…

This early-stage study tested a single injection of a new drug called HRS-5632 in 50 healthy adults to see if it is safe and how the body processes it. The goal is to eventually treat dyslipidemia (abnormal cholesterol levels). Since it is a Phase 1 trial in healthy people, it fo…

This early-stage study tested a new drug called HRS-7450 in 64 adults who had an acute ischemic stroke (a stroke caused by a blood clot). The main goal was to see if the drug is safe and tolerable, especially regarding the risk of bleeding in the brain. Researchers also looked at…

This early-stage study tested a new drug called HRS-9057 in 25 adults with heart failure who still had fluid buildup despite taking diuretics. The goal was to see if the drug is safe and helps remove excess fluid, compared to an existing medication (tolvaptan). The study focused …

This study tested a new drug called HR20013 against an existing drug (palonosetron) to see which better prevents nausea and vomiting in cancer patients receiving moderate-risk chemotherapy. 706 adults with cancer who had never had chemo before took part. The goal was to see if HR…

This study looked at how the drug HRS9531 enters and leaves the body in people with different levels of kidney function. Researchers compared 32 adults with normal kidneys to those with mild or moderate kidney impairment. The goal was to see if kidney problems change how the drug…